Merck & Co Inc. (MRK) News Headlines

▮ More

Date

Headline

1/12/2021 7:17:06 AM Merck : FDA Accepts For Priority Review BLA For Adult Invasive Pneumococcal Vaccine

1/12/2021 6:55:52 AM Merck: FDA Accepts For Priority Review A BLA For V114 For Prevention Of Invasive Pneumococcal Disease

1/7/2021 6:09:27 AM Merck Acquires AmpTec - Quick Facts

12/29/2020 1:53:14 AM Biotech Stocks Facing FDA Decision In January 2021

12/28/2020 7:06:40 AM AstraZeneca : Japan Approves Lynparza To Treat Three Types Of Advanced Cancer

12/23/2020 7:31:35 AM Merck Collaborates With U.S. Government To Advance Investigational Biological Therapy For COVID-19

12/23/2020 7:18:34 AM Merck Announces Supply Deal For Initial Doses Of Investigational Biological Therapy For COVID-19

12/17/2020 7:51:46 AM Merck: FDA Grants Priority Review To SBLA For Keytruda Plus Chemotherapy

12/17/2020 7:18:56 AM Merck Says FDA Grants Priority Review To SBLA For KEYTRUDA Plus Chemotherapy

12/16/2020 7:45:06 AM Merck : Keytruda Plus Lenvima Meets Primary Goal In Phase 3 Trial On Advanced Endometrial Cancer

12/16/2020 7:07:04 AM Merck Says Pivotal Phase 3 KEYNOTE-775/Study 309 Trial Met Its Dual Primary Endpoints

12/11/2020 7:40:34 AM Merck Reports Positive CHMP Opinion For KEYTRUDA - Quick Facts

12/11/2020 7:37:10 AM Merck Says CHMP Of EMA Adopted Positive Opinion Recommending Approval Of KEYTRUDA

12/10/2020 1:47:53 PM Coalition Of CEOs Pledge 1 Mln Jobs For Black Americans

12/2/2020 8:36:40 AM Merck Sells Direct Holding In Moderna - Quick Facts

12/2/2020 8:22:28 AM Merck Divests Its Direct Holding In Moderna

11/24/2020 1:55:02 AM AZN's COVID Shot 70% Effective On Average, ARQT Aces Scalp Psoriasis Study, BLRX' BLAST Fizzles

11/23/2020 7:43:39 AM Merck To Buy OncoImmune; Submits Applications For 15-valent Pneumococcal Conjugate Vaccine

11/23/2020 7:21:44 AM Merck Submits Applications To FDA And EMA For Licensure Of V114

11/23/2020 7:20:20 AM Merck To Acquire OncoImmune For An Upfront Payment Of $425 Mln